A RECK-WNT7 receptor-ligand interaction enables isoform-specific regulation of Wnt bioavailability by Vallon, Mario et al.
TitleA RECK-WNT7 receptor-ligand interaction enables isoform-specific regulation of Wnt bioavailability
Author(s)
Vallon, Mario; Yuki, Kanako; Nguyen, Thi D.; Chang, Junlei;
Yuan, Jenny; Siepe, Dirk; Miao, Yi; Essler, Markus; Noda,
Makoto; Garcia, K. Christopher; Kuo, Calvin J.











A RECK-WNT7 Receptor-Ligand Interaction Enables
Isoform-Specific Regulation of Wnt Bioavailability
Graphical Abstract
Highlights
d RECK is the predominant binding partner of GPR124 in rat
brain blood vessels in situ
d RECK/WNT7 signaling is primarily regulated by the GPR124
ectodomain
d RECK is a WNT7 receptor that stabilizes short-lived, active,
monomeric WNT7
d RECK-bound WNT7 binds Frizzled receptors more readily
than does free WNT7
Authors
Mario Vallon, Kanako Yuki,
Thi D. Nguyen, ..., Makoto Noda,




Canonical Wnt/b-catenin signaling in
brain endothelium is highly specialized
and requires the WNT7-specific co-
activators RECK and GPR124 in addition
to the Wnt co-receptors FZD and LRP.
Here, Vallon et al. demonstrate direct
binding of WNT7 to RECK resulting in
stabilization of active WNT7 and
increased FZD:WNT7 complex formation.
Vallon et al., 2018, Cell Reports 25, 339–349




A RECK-WNT7 Receptor-Ligand Interaction Enables
Isoform-Specific Regulation of Wnt Bioavailability
Mario Vallon,1 Kanako Yuki,1 Thi D. Nguyen,1 Junlei Chang,1,5 Jenny Yuan,1 Dirk Siepe,2 Yi Miao,2 Markus Essler,3
Makoto Noda,4 K. Christopher Garcia,2 and Calvin J. Kuo1,6,*
1Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA 94305, USA
2Department of Molecular and Cellular Physiology, Department of Structural Biology, and Howard Hughes Medical Institute,
Stanford University School of Medicine, Stanford, CA 94305, USA
3Department of Nuclear Medicine, University Hospital Bonn, 53127 Bonn, Germany
4Department of Molecular Oncology, Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto 606-8501, Japan





WNT7A and WNT7B control CNS angiogenesis and
blood-brain barrier formation by activating endothe-
lial Wnt/b-catenin signaling. The GPI-anchored pro-
tein RECK and adhesion G protein-coupled receptor
GPR124 critically regulate WNT7-specific signaling
in concert with FZD and LRP co-receptors. Here,
we demonstrate that primarily the GPR124 ectodo-
main, but not its transmembrane and intracellular
domains, mediates RECK/WNT7-induced canonical
Wnt signaling. Moreover, RECK is the predominant
binding partner of GPR124 in rat brain blood vessels
in situ. WNT7A and WNT7B, but not WNT3A, directly
bind to purified recombinant soluble RECK, full-
length cell surface RECK, and the GPR124:RECK
complex. Chemical cross-linking indicates that
RECK and WNT7A associate with 1:1 stoichiometry,
which stabilizes short-lived, active, monomeric, hy-
drophobic WNT7A. In contrast, free WNT7A rapidly
converts into inactive, hydrophilic aggregates. Over-
all, RECK is a selective WNT7 receptor that mediates
GPR124/FZD/LRP-dependent canonical Wnt/b-cat-
enin signaling by stabilizing active cell surface
WNT7, suggesting isoform-specific regulation of
Wnt bioavailability.
INTRODUCTION
Canonical Wnt/b-catenin signaling is activated byWnt-mediated
heterodimerization of Frizzled (FZD1-10) and low-density lipo-
protein receptor-related proteins 5 or 6 (LRP5/6) co-receptors,
which stabilizes the T cell factor/lymphoid enhancer-binding fac-
tor (TCF/LEF) activator b-catenin to transcribe Wnt target genes
(Clevers and Nusse, 2012; Janda et al., 2017). In the CNS, ca-
nonical Wnt signaling critically regulates embryonic CNS angio-
genesis and blood-brain barrier (BBB) formation (Daneman et al.,
2009; Stenman et al., 2008; Zhou et al., 2014), postnatal BBB
function (Wang et al., 2012), and adult pathologic BBB integrity
(Chang et al., 2017). Wnt7a and Wnt7b expressed in embryonic
neuroepithelium activate endothelial canonical Wnt signaling
(Daneman et al., 2009; Stenman et al., 2008). Wnt activity corre-
lates with its hydrophobicity (Kakugawa et al., 2015; Zhang et al.,
2012), a result of its palmitoylation and essential for FZD binding
(Janda et al., 2012).
Fzd4, the major canonical FZD in CNS endothelium (Daneman
et al., 2009; Zhang et al., 2014), regulates postnatal retinal angio-
genesis, blood-retinal barrier formation, and cerebellar BBB
integrity (Wang et al., 2012; Zhou et al., 2014). CNS endothelial
cells also express Fzd1 and Fzd8 (Daneman et al., 2009; Zhang
et al., 2014), which may act redundantly with Fzd4, as no single
Fzd knockout (KO) affects embryonic CNS vasculature (Wang
et al., 2016). CNS endothelial canonical Wnt signaling is highly
specialized and requires WNT7-specific co-activators GPR124
and RECK or alternatively the FZD4-specific ligand Norrin and
co-receptor TSPAN12 (Cho et al., 2017; Junge et al., 2009; Ulrich
et al., 2016; Wang et al., 2012; Zhou and Nathans, 2014; Zhou
et al., 2014).
GPR124 (TEM5/ADGRA2) is an orphan adhesion family G pro-
tein-coupled receptor (GPCR) with characteristic large ectodo-
main (ECD) (Hamann et al., 2015). MurineGpr124 KO profoundly
impairs embryonic CNS angiogenesis and BBB maturation in
forebrain and ventral neural tube (Kuhnert et al., 2010), similar
to Wnt7a/; Wnt7b/ mice (Daneman et al., 2009; Stenman
et al., 2008). The Gpr124 KO is rescued by endothelial-specific
constitutive Wnt/b-catenin signaling (Zhou and Nathans, 2014).
Conditional adult Gpr124 KO is well tolerated under homeosta-
sis, but exacerbates BBB breakdown and CNS hemorrhage dur-
ing ischemic stroke and glioblastoma, which is also rescued by
constitutive b-catenin activation (Chang et al., 2017).
The glycosylphosphatidylinositol (GPI)-anchored protein
reversion-inducing cysteine-rich protein with kazal motifs
(RECK) is a metalloproteinase inhibitor (Oh et al., 2001) and reg-
ulates canonical Wnt/b-catenin signaling (Vanhollebeke et al.,
2015; Cho et al., 2017; Ulrich et al., 2016). While global Reck
KO mice die at midgestation prior to CNS angiogenesis (Oh
et al., 2001), endothelial-specific Reck KO mice die later (de
Almeida et al., 2015) with CNS angiogenesis defects and hemor-
rhage similar to Gpr124/ or Wnt7a/; Wnt7b/ mice (Cho
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et al., 2017; Daneman et al., 2009; Kuhnert et al., 2010; Stenman
et al., 2008). GPR124, RECK, FZDs, and LRP5/6 synergistically
mediate WNT7-specific canonical Wnt reporter activation
in vitro (Vanhollebeke et al., 2015). Zebrafish CNS endothelial
tip cell formation requires both gpr124 and reck cell-autono-
mously (Vanhollebeke et al., 2015), endothelial Gpr124 and
Reck cooperate during murine CNS angiogenesis and BBB for-
mation, recombinant GPR124 and RECK fragments interact
physically in vitro, and mouse Reck KO is rescued by endothelial
constitutive Wnt signaling activation (Cho et al., 2017).
Here, we demonstrate that canonical WNT7 signaling is
primarily regulated by the GPR124 ECD, but not by its trans-
membrane domain (TMD) and intracellular domain (ICD), sug-
gesting extracellular GPR124 action rather than intrinsic
GPR124 signal transduction. Importantly, WNT7 directly binds
RECK and the GPR124:RECK complex, which stabilizes WNT7
in its active, monomeric, hydrophobic form and enhances
WNT7 binding to FZD.
RESULTS
GPR124-Mediated Canonical WNT7 Signaling Does Not
Require GPR124 Signal Transduction
We confirmed RECK as a predominant binding partner of
GPR124 in rat brain blood vessels in situ by combined chemical
cross-linking/affinity chromatography (Figures 1A and S1A). To
characterize the GPR124:RECK binding interface, recombinant
soluble GPR124 ECD (sGPR124) or sGPR124 mutants lacking
individual subdomains were tested for binding to recombinant
soluble (DGPI) Fc-tagged RECK (sRECK-Fc) by Protein A pull-
down. While sGPR124 Dhormone receptor domain (DHRM)
still bound sRECK-Fc, albeit less efficiently than wild-type
sGPR124, mutants lacking the leucine-rich repeat domain
(DLRR) or the GPCR autoproteolysis-inducing domain (DGAIN)
did not bind sRECK-Fc (Figures 1B and S1B). Cross-linking
mass spectrometry of the sGPR124:sRECK-Fc complex re-
vealed extensive interactions between GPR124 LRR/GAIN and
RECK cystine knot motif (CK)/EGF2 domains, confirming the
pull-down studies and further suggesting interaction between
GPR124 GAIN and RECK EGF2 (Figures 1C and S1C; Table S1).
GPR124/WNT7 co-transfection of HEK293 cells activates the
canonical Wnt/b-catenin luciferase reporter Super TOP-Flash
(STF), which is further enhanced by additional RECK co-trans-
fection (Cho et al., 2017; Vanhollebeke et al., 2015) (Figure S1D).
HEK293 cells endogenously express RECK, but not GPR124
protein (Figure S1E). GPR124/WNT7-mediated STF activation
was completely abolished in HEK293 RECK/ cells (generated
by CRISPR/Cas9 KO), and restored upon RECK transfection
(Figures S1E and S1F), indicating that GPR124 absolutely re-
quires RECK to induce canonical WNT7 signaling.
Whether the GPR124:RECK complex intrinsically transduces
a WNT7-dependent signal into the cell that synergizes with
FZD/WNT7/LRP signaling is unknown. We thus tested GPR124
mutants for RECK/WNT7-dependent STF activation, which
was normalized to GPR124 mutant cell surface expression (Fig-
ures 1D, S2A, and S2B). GPR124 ECD deletion completely
abrogated reporter activation, but surprisingly ICD deletion
only partially impaired signaling by 22% (Figure 1D). Further,
the GPR124 ECD fused to the single-pass TMD of VEGFR2
without the tyrosine kinase domain (membrane-bound ECD
[mbECD]) mediated RECK/WNT7-dependent STF activation,
albeit less than full-length GPR124 (Figure 1D). Addition of
purified recombinant soluble GPR124 ECD (sGPR124-Fc, Fig-
ure S1B) to the culture medium was fully sufficient to activate
RECK/WNT7-dependent STF to the same extent as full-length
GPR124 (Figure 1E). Purified recombinant sGPR124 subdomain
deletion mutants (Figures 1F and S1B) variably activated RECK/
WNT7 signaling: DLRR and DGAIN mutants were inactive and
DHRM partially active (Figure 1F), correlating with RECK binding
(Figures 1B and 1C). Although variably expressed on the cell
surface, all RECK single domain deletion mutants were inactive
or only minimally active in STF assays (Figures S2C and S2D).
Co-culture STF assays revealed that GPR124:RECK cis (same
cell), but not trans (opposing cells) interactions promoted canon-
ical WNT7 signaling (Figure S2E). Although the metalloprotei-
nase inhibitor function of RECK (Oh et al., 2001) could potentially
mediate GPR124/WNT7-dependent STF activation, the pan-
metalloproteinase inhibitor GM6001 (Ilomastat) did not mimic
RECK-mediated GPR124/WNT7 signaling (Figure S2F). We
also formally confirmed that GPR124/RECK/WNT7A-induced
STF activation correlates with increased cytosolic b-catenin
levels (Figure S2G).
RECK Is a WNT7 Receptor
Despite remarkable convergence ofWnt7,Gpr124, andReckKO
phenotypes, it is not known if WNT7 functionally couples to
GPR124/RECK via direct binding or throughmore indirect mech-
anisms (Noda et al., 2016). RECK contains a FZD-like cysteine-
rich domain (CRD) (Figure S3A) (Pei and Grishin, 2012) that
could directly bind WNT7, analogous to Wnt binding to the CRD
of FZDs (Janda et al., 2012). Potential WNT7 binding to sRECK-
Fc or sGPR124-Fc was tested using a co-pull-down assay.
HEK293 RECK/ cells stably transfected with WNT7A
(HEK293 RECK/ WNT7A cells) were cultured with sRECK-Fc
or sGPR124-Fc protein added to the culture medium to poten-
tially capture newly secreted WNT7A. Protein A pull-down of
sRECK-Fc from conditioned medium (CM) resulted in co-
purification of WNT7A (Figure 2A). In contrast, WNT7A did not
appreciably bind sGPR124-Fc. WNT7B released from HEK293
RECK/ WNT7B cells also bound to sRECK-Fc, but not to
VEGFR2 ECD-Fc used as negative control (Figure S3B). Analo-
gous studies using HEK293 RECK/ WNT3A cells showed ex-
pected binding of WNT3A to sFZD4-Fc and sFZD8-Fc positive
controls but not to sRECK-Fc or sGPR124-Fc (Figure 2B), further
asserting the specificity of the RECK:WNT7 interaction. Further-
more, sRECK-Fc protein dose-dependently inhibited RECK/
GPR124/WNT7B- (Figure 2C) but notWNT3A-mediatedSTFacti-
vation (Figure S3C).We also used solubleRECKdeletionmutants
to map domains binding WNT7A. Only RECK DCK and DCRD
mutants were secreted from HEK293 cells (Figure S1B and data
not shown) and thus usable for binding studies; both sRECK
DCK and DCRD were defective in WNT7A binding (Figure 2D).
Because sRECK and sGPR124 might not completely recapit-
ulate WNT7 binding of the cognate full-length proteins, we also
assessed WNT7A binding to full-length cell surface GPR124
and RECK. HEK293 RECK/ WNT7A cells were transfected
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with SNAP-GPR124 or SNAP-RECK fusion constructs, which
were active in STF assays and similarly expressed on the cell
surface (Figures S3D and S3E). The SNAP tag was specifically
biotinylated (bSNAP) and cell surface protein complexes stabi-
lized in situ by the non-cell-permeable, thiol-cleavable chemical
cross-linker DTSSP. Streptavidin pull-down from cell lysates
under denaturing conditions followed by cross-link reversal
showed co-pull-down of WNT7A with bSNAP-RECK, but not
bSNAP-GPR124 (Figure 2E). Without prior cell surface cross-
linking, WNT7A was not pulled down by bSNAP-RECK (Fig-
ure 2E). On HEK293 RECK/ WNT3A cells bSNAP-FZD4, but
not bSNAP-RECK and bSNAP-GPR124 bound WNT3A (Fig-
ure 2F), further confirming specificity of the interaction between
cell surface RECK and WNT7A.
WNT7A Binds to FZDs and LRP5/6
We also assessed WNT7A binding to the archetypal Wnt recep-
tors FZD4 and FZD8, both expressed in CNS endothelium, with
Fzd4 being predominantly expressed (Daneman et al., 2009;
Zhang et al., 2014). Interestingly, neither full-length SNAP-Fzd4
expressed on the cell surface (Figures 2E and S3E), nor recom-
binant sFZD4-Fc detectably bound transfected WNT7A, and
only trace WNT7A binding was seen with sFZD4-His (Figures
2A and S3F; Table S2). However, STF reporter activation in
Figure 1. Canonical RECK/GPR124/WNT7 Signaling Does Not Require Intrinsic GPR124 Signal Transduction
(A) Co-purification of RECK with GPR124 by aGPR124 affinity chromatography from rat brain blood vessels. Where indicated, proteins in isolated brain blood
vessels were cross-linked in situ using DSP. Arrows depict proteins excised and identified by mass spectrometry.
(B) Binding of purified sGPR124 proteins (5 nM) to purified sRECK-Fc (50 nM) as assessed by Protein A pull-down.
(C) Cross-linking mass spectrometric analysis of the purified sGPR124:sRECK-Fc complex. Red lines indicate mass spectrometry-inferred cross-links between
adjacent lysine residues within the protein complex.
(D) Analysis of GPR124 mutants in Super TOP-Flash (STF) canonical Wnt/b-catenin reporter assay. Cells were co-transfected with the indicated expression
constructs and STF/RLuc reporters for 48 hr. STF activity was normalized with RLuc activity and cell surface expression levels (OD410) of the corresponding
GPR124mutant. mbECD is a fusion of the GPR124 ECD and the VEGFR2 TMD. FL, full-length; mb, membrane-bound. Mean (n = 3) ± SD. *p < 0.05 versus RECK/
WNT7B only.
(E and F) Activity of sGPR124-Fc (E) or sGPR124 deletion mutant proteins (F) in STF assays. Cells were co-transfected with indicated expression constructs and
STF/RLuc reporters. 24 hr after transfection indicated proteins were added at 0, 10, 100, or 1,000 nM (wedges). 24 hr later STF activity was determined and
normalized to RLuc activity. Mean (n = 3) ± SD. WT, wild-type. *p < 0.05 versus no protein.
All western blots (WB) were performed under reducing conditions. All data are representative of at least two independent experiments with similar results. LRR,
leucine-rich repeat; CT, C-terminal; IG, immunoglobulin; HRM, hormone receptor; GAIN, GPCR autoproteolysis-inducing; CK, cystine knot motif; CRD, cysteine-
rich domain; EGF, epidermal growth factor; s, soluble ECD; Fc, IgG Fc fragment.
See also Figures S1 and S2 and Table S1.
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Lrp5/WNT7A-co-transfected HEK293 RECK/ cells was
modestly increased by Fzd4 (Figure S3G), suggesting low affinity
WNT7A binding to FZD4. In contrast, sFZD8 boundWNT7A even
more efficiently than sRECK (Figure 2A) and both sFZD4 and
sFZD8 bound WNT3A (Figure 2B). GPR124/RECK/WNT7 over-
expression activated the STF reporter in parental, but not in
FZD1/2/4/5/7/8 KO HEK293T cells (Voloshanenko et al., 2017),
whereas both cell lines mediated similar STF activation upon
Fzd8/WNT7 overexpression (Figure S3H), indicating that endog-
enous FZDs mediate GPR124/RECK/WNT7 signaling. Both re-
combinant LRP5 and LRP6 ECDs bound WNT7A in HEK293
RECK/ WNT7A CM (Figures S3F and S4A; Table S2). Further,
recombinant Dickkopf-1 (DKK1), an LRP5/6 antagonist (Mao
et al., 2001), dose-dependently inhibited RECK/GPR124/
WNT7-mediated STF activation (Figure S4B).
RECK Binding Stabilizes Short-Lived, Active,
Monomeric, Hydrophobic WNT7A
Interestingly,WNT7Abinding toRECKorFZD8wasonlyobserved
whensRECKor sFZD8proteins hadbeen added to themediumof
WNT7A-expressing cells to capture newly secreted WNT7A (Fig-
ure 3A). In contrast,WNT7A in harvested, cell-freeWNT7ACMdid
not bind recombinant sRECKor sFZD8 (Figure 3A), indicating that
activeWNT7A is very short-lived.Moreover, neither commercially
available recombinant WNT7A (PeproTech) nor WNT7A/7B CM
mediated GPR124/RECK-dependent STF activation in HEK293
Figure 2. RECK Is a WNT7 Receptor
(A) WNT7A binds to RECK and FZD8. HEK293 RECK/ WNT7A cells were cultured in medium supplemented with indicated purified proteins (25 nM) for 72 hr
and CM subjected to Protein A pull-down.
(B) WNT3A binds to FZD4 and FZD8, but not to GPR124 and RECK. HEK293 RECK/ WNT3A cells were cultured in medium supplemented with indicated
purified proteins (25 nM) for 72 hr and CM subjected to Protein A pull-down.
(C) Super TOP-Flash (STF) canonical Wnt/b-catenin reporter gene assay. HEK293 RECK+/+ or RECK/ cells were co-transfected with the indicated expression
constructs and STF/RLuc reporters. 24 hr after transfection sRECK-Fc protein was added at 0, 10, 100, or 1,000 nM (wedges). 24 hr later STF activity was
normalized with RLuc activity. Mean (n = 3) ± SD. *p < 0.05 versus no protein.
(D) WNT7A binding to RECK is mediated by RECK cystine knot motif (CK) and cysteine-rich domains (CRD). HEK293 RECK/WNT7A cell culture medium was
supplemented with the indicated proteins (3 nM) and conditioned for 96 hr. CM were subjected to Protein A pull-down.
(E and F) Cell surface RECK binds toWNT7A, but not to WNT3A. HEK293RECK/WNT7A (E) orWNT3A (F) cells were transfected with the indicated expression
constructs. 48 hr after transfection, SNAP tags were specifically biotinylated (bSNAP) and cell surface proteins cross-linked in situ using DTSSP (100 mM). Cells
were lysed, subjected to streptavidin pull-down, and cross-links reversed. WCL, whole cell lysate.
All western blots (WB) were performed under reducing conditions. All data are representative of at least two independent experiments with similar results. CM,
conditioned medium; s, soluble ECD; Fc, IgG Fc fragment.
See also Figure S3 and Table S2.
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Figure 3. RECK Binding Stabilizes Short-Lived, Active, Monomeric, Hydrophobic WNT7A
(A) RECK and FZD8 only bind newly secreted WNT7A. Culture media of HEK293 RECK/WNT7A cells were supplemented with the indicated proteins (100 nM)
and conditioned for 72 hr (‘‘during conditioning’’). Alternatively, the indicated proteins were added to the CM after harvesting after 72h (‘‘after conditioning’’). CM
were subjected to Protein A pull-down.
(B and C) CM fromHEK293RECK/WNT7A (B) orWNT3A (C) cells were analyzed by reducing (+DTT) or non-reducing (DTT) SDS-PAGE/WB.Where indicated
CM were subjected to Triton X-114 phase separation.
(D) sRECK-Fc protein stabilizes newly secreted, monomeric, hydrophobic WNT7A. Culture medium of HEK293 RECK/ WNT7A cells was supplemented with
indicated proteins (100 nM) and conditioned for 72 hr (‘‘during conditioning’’). Alternatively, indicated proteinswere added to CMafter harvesting after 72 hr (‘‘after
conditioning’’). CM aliquots were subjected to Triton X-114 phase separation and remaining CM to Protein A pull-down followed by Triton X-114 phase separation
of pull-downs and unbound supernatants. Irrelevant lanes (between lanes 4 and 5) have been removed from the WB.
(legend continued on next page)
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(Figures S4C and S4D). In contrast, recombinant WNT3A
protein (PeproTech) and WNT3A CM activated STF (Figures
S4C and S4D).
Wnt activity correlates with its hydrophobicity, a result of its
palmitoylation and essential for FZD binding (Janda et al.,
2012). Loss of Wnt hydrophobicity by removal of the lipid group
and/or aggregation is inactivating (Kakugawa et al., 2015; Zhang
et al., 2012). To determine hydrophobicity/activity of CM-derived
WNT7A, we used the detergent Triton X-114, which dissolves in
aqueous buffers at 4C, but separates into a detergent phase
above 20C, drawing hydrophobic molecules from the aqueous
buffer into the detergent phase (Bordier, 1981).
Analysis of CM from HEK293 RECK/ WNT7A/WNT3A cells
by non-reducing (-DTT) SDS-PAGE/western blotting revealed
that WNT7A/WNT3A exist as both (1) monomeric and/or non-
covalently aggregated species (45 kDa), as well as (2) covalent
aggregates (>120 kDa) (Figures 3B and 3C, lane 2). Both WNT7A
and WNT3A covalent aggregates collapsed to monomers upon
DTT reduction (+DTT), indicating intermolecular disulfide bonds
(Figures 3B and 3C, lane 1 versus lane 2). Interestingly, both
low and high MW WNT7A species partitioned into the aqueous,
but not the detergent phase upon Triton X-114 phase separation
(Figure 3B, lanes 5–7), correlating with lack of STF activation
by WNT7A CM (Figure S4C). In contrast, low MWWNT3A exclu-
sively partitioned into the detergent phase (Figure 3C, lanes 5–7),
correlating with STF activation by WNT3A CM (Figure S4C).
To determine, if CM-derived low MW WNT7A in non-reducing
SDS-PAGE is amonomer and/or oligomer under non-denaturing
conditions, we performed size exclusion chromatography (Fig-
ure S4E). The 45 kDa WNT7A species was present in elution
fractions corresponding to 100–500 kDa indicating that WNT7A
predominantly forms large aggregates in CM in vitro. Similar
aggregation might occur in vivo as most WNT7A in E12.5
mouse forebrain extracts partitioned into the Triton X-114
aqueous phase as covalent aggregates (Figure S4F). In contrast,
E12.5 mouse forebrain WNT3A equally partitioned into the Triton
X-114 detergent and aqueous phases as low MW species
(Figure S4G).
Next, HEK293 RECK/WNT7A cells were allowed to secrete
WNT7A into culture medium supplemented with sGPR124-Fc or
sRECK-Fc protein (i.e., ‘‘during conditioning’’) followed by Triton
X-114 phase separation of the CM. Non-reducing SDS-PAGE/
western blotting of detergent and aqueous phases revealed
that sRECK-Fc, but not sGPR124-Fc, stabilized hydrophobic/
detergent phase WNT7A (Figure 3D, ‘‘Input’’ lanes 5–8). How-
ever, when WNT7A CM was harvested first and recombinant
sRECK-Fc added under cell-free conditions (i.e., ‘‘after condi-
tioning’’), hydrophilic WNT7A did not convert to the hydrophobic
form (Figure 3D, ‘‘Input’’ lanes 3 and 4).
Protein A pull-down from the CM (without Triton X-114)
followed by Triton X-114 phase separation was performed to
determine which WNT7A species bound sRECK-Fc. Triton
X-114 phase separation selectively eluted WNT7A from the
Protein A/sRECK-Fc/WNT7A beads (Figure S4H). When recom-
binant sRECK-Fc had been added to the culture medium of live
cells (i.e., ‘‘during conditioning’’), low MW, but not high MW
WNT7A, was found in the Protein A pull-down eluate and exclu-
sively partitioned into the detergent phase (Figure 3D, ‘‘Protein
A-bound’’ lanes 7 and 8). Conversely, Triton X-114 phase sepa-
ration of the unbound supernatants from the Protein A/sRECK-
Fc pull-down showed depletion of WNT7A from the detergent,
but not the aqueous phase (Figure 3D, ‘‘Protein A-unbound’’
lanes 7 and 8). No WNT7A was detectable in the Protein A
pull-downwhen sRECK-Fc had been added to the CM after con-
ditioning (Figure 3C, ‘‘Protein A-bound’’ lanes 3 and 4).
Hydrophobic WNT7A bound to RECK could be monomeric
or oligomeric under non-denaturing conditions. To test if RECK
binds monomeric or oligomeric WNT7A, the purified
sRECK:WNT7A complex was covalently cross-linked with non-
cleavable BS3. Western blotting revealed a cross-linker dose-
dependent shift of non-cross-linked sRECK (140 kDa) and
WNT7A (50 kDa) to a single, cross-linked band at 190 kDa
representing a 1:1 complex of sRECK and WNT7A, indicating
that RECK directly binds monomeric WNT7A without participa-
tion of accessory proteins (Figure 3E).
Similar to WNT7A eluted from sRECK, WNT7A eluted from
sFZD8 mainly partitioned into the Triton X-114 detergent phase
(Figure S5A). sRECK stabilization of WNT7A in CM was, how-
ever,more efficient than equimolar sFZD8or sLRP6 (Figure S5B).
Combinations of different recombinant receptor ECDs in CM
elicited modest additive, but not synergistic WNT7A stabiliza-
tion. Further, GPR124 did not regulate WNT7A stabilization by
RECK (Figure S5B).
The aggregation inactivation of WNT7A might be intrinsic to
this protein or mediated by Wnt-inactivating enzymes (Kaku-
gawa et al., 2015; Zhang et al., 2012). If Wnt-inactivating en-
zymes in HEK293 inactivated WNT7A, purified hydrophobic
WNT7A should be stable under cell-free conditions similar to pu-
rifiedWNT3A (Willert et al., 2003). Thus, we purified hydrophobic
WNT7A in complex with sRECK or sFZD8 and specifically eluted
WNT7A by low pH followed by neutralization, incubation at 37C,
and Triton X-114 phase separation (Figure 3F). Notably, by
60 min post-elution, hydrophobic WNT7A had completely
converted to the hydrophilic form, suggesting that aggregation
(E) RECK and WNT7A form a 1:1 complex. Expi293F cells were co-transfected with sRECK-His and WNT7A. 96 hr after transfection CM was harvested
and sRECK-His:WNT7A complex purified by combined chemical cross-linking (BS3)/tandem affinity purification. Purified complex was analyzed by reducing
SDS-PAGE/WB.
(F) Free, hydrophobic WNT7A is highly unstable. sRECK-Fc:WNT7A, sFZD8-Fc-Biotin:WNT7A, and sFZD8-Fc-Biotin:WNT3A complexes were isolated from the
corresponding HEK293 RECK/ WNT7A/WNT3A CM (96 hr, 100 nM recombinant protein) using Protein A or streptavidin agarose. Bound Wnt proteins were
eluted by low pH, neutralized, diluted into PBS/10% FBS and incubated at 37C. At indicated time points Wnt eluate was subjected to Triton X-114 phase
separation.
All data are representative of at least two independent experiments with similar results. CM, conditionedmedium;WB, western blot; T, total; De, detergent phase;
Aq, aqueous phase; s, soluble ECD; Fc, IgG Fc fragment.
See also Figures S4 and S5.
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inactivation is intrinsic toWNT7A and not mediated byWnt-inac-
tivating enzymes. In contrast, WNT3A eluted from sFZD8 was
stable and hydrophobic at 37C for at least 120 min (Figure 3F).
GPR124, RECK, and WNT7A Form a Ternary Complex
To test if RECK can assemble a ternary GPR124/RECK/WNT7A
complex, sGPR124 and sRECK-Fc proteins were added to
medium of HEK293RECK/WNT7A cells during culture and al-
lowed to form complexes. Upon Protein A pull-down from the
CM, both sGPR124 and WNT7A co-purified with sRECK-Fc
(Figure 4A), indicating ternary GPR124/RECK/WNT7A complex
formation. However, WNT7A binding to sRECK-Fc was not regu-
lated by sGPR124 (Figure 4A, lanes 2 and 3) and sRECK-
Fc:sGPR124 complex formation was not regulated by WNT7A
(Figure 4A, lanes 1 and 2). Neither sGPR124 nor WNT7A co-pu-
rifiedwith negative control sEPHB4-Fc (Figure 4A, lanes 4 and 5).
Because sRECK-Fc pull-downmight show independent sRECK-
Fc:WNT7A and sRECK-Fc:sGPR124 complexes without ternary
complex formation, we performed a control sGPR124 pull-down.
sRECK andWNT7A both co-purifiedwith sGPR124 (Figure S5C),
confirming ternary GPR124/RECK/WNT7A complex formation,
as GPR124 does not directly bind WNT7A (Figure 2A).
Potential regulation of RECK:WNT7A complex formation by
GPR124 on the cell surface was investigated by co-transfec-
tion of HEK293 RECK/ WNT7A cells with SNAP-RECK and
GPR124. SNAP-RECK was specifically biotinylated (bSNAP-
RECK) and cell surface protein complexes stabilized in situ using
the thiol-cleavable chemical cross-linker DTSSP. Streptavidin
pull-down of bSNAP-RECK from cell lysates followed by
cross-link reversal revealed similar WNT7A co-pull-down with
and without GPR124 co-transfection (Figure 4B). WNT7A did
not co-purify with negative control bSNAP-b2AR (Figure 4B).
Because GPR124 regulation of RECK/WNT7 signaling was
not mediated by modulating RECK:WNT7A complex formation,
we tested if GPR124 regulates RECK cell surface expression.
HEK293 RECK/ cells were transfected with GPR124 and/or
RECK and cell surface proteins isolated by cell surface bio-
tinylation/streptavidin pull-down. Interestingly, RECK cell sur-
face, but not total expression levels were drastically increased
by GPR124 co-expression (Figure S5D). In contrast, cell surface
GPR124 was slightly decreased by RECK. However, cell surface
RECK expression was not decreased by Gpr124 conditional KO
(Gpr124D/) in primary brain endothelial cells (Figure S5E), indi-
cating potential functional differences between overexpressed
and endogenous GPR124.
RECK Promotes FZD8:WNT7A Complex Formation
To address potential formation of a multi-protein receptor
complex consisting of GPR124, RECK, FZD4/FZD8, and
WNT7A, wemixed the corresponding purified ECDswith purified
sRECK:WNT7A complex. Protein A pull-down of sFZD4-Fc or
sFZD8-Fc from the protein mixture did not detectably co-precip-
itate sGPR124 or sRECK (Figure 4C). However, WNT7A co-puri-
fied with sFZD8-Fc possibly by relay of WNT7A from sRECK to
sFZD8-Fc, because the resultant sFZD8-Fc:WNT7A complex
lacked sRECK (Figure 4C, lane 8). Relay of WNT7A from sRECK
to sFZD8-Fc was GPR124-independent (Figure 4C, lanes 7
and 8). Consistently, sFZD8, but not sFZD4, dose-dependently
eluted WNT7A from sRECK-Fc:WNT7A immobilized on
Protein A agarose, suggesting mutually exclusive, sequential
binding of WNT7 to RECK and then FZD (Figure 4D).
We also determined potential competition between FZD and
RECK for WNT7A binding. Equimolar amounts of sFZD4-Fc/
sFZD8-Fc and sRECK-His proteins were added to the medium
of HEK293 RECK/WNT7A cells and allowed to capture newly
secreted WNT7A. In sequential pull-downs, WNT7A preferen-
tially bound to sFZD8-Fc over sRECK-His, but preferred
sRECK-His over sFZD4-Fc (Figure 4E). Although WNT7A prefer-
entially bound sFZD8, sRECK-Fc markedly increased
sFZD8:WNT7A complexes in CM of HEK293 RECK/ WNT7A
cells (Figure 4F), suggesting that RECK might present WNT7A
to FZDs in a manner that favors FZD binding, ultimately leading
to relay of WNT7A from RECK to FZD.
DISCUSSION
Despite remarkable convergence of Gpr124, Wnt7a/7b and
Reck KO phenotypes (Cho et al., 2017; Daneman et al., 2009;
de Almeida et al., 2015; Kuhnert et al., 2010; Stenman et al.,
2008) and their synergistic activation of Wnt signaling (Cho
et al., 2017; Vanhollebeke et al., 2015; Zhou and Nathans,
2014), molecular mechanisms of the GPR124/RECK/WNT7
intersection have been elusive. Here, we identified GPI-
anchored RECK as a specific WNT7 receptor. During the revi-
sion of this manuscript, RECK was reported as a WNT7 receptor
based on proximity ligation assays and micromolar binding of
WNT7 peptides to the RECK CK domain (Eubelen et al.,
2018). Our study also implicates the RECK CK domain in
WNT7 binding. However, Wnt proteins bind to the CRD of
FZD receptors (Janda et al., 2012) and RECK contains a FZD-
like CRD (Pei and Grishin, 2012) that we identified as also essen-
tial for WNT7 binding. Competitive elution of WNT7A from RECK
by the FZD8 ECD without stable RECK/WNT7/FZD8 ternary
complex formation infers that the RECK binding site on WNT7
is similar to, or overlaps with the FZD binding site on Wnts
(Janda et al., 2012). Potentially, both RECK CK and CRD do-
mains cooperatively modulate WNT7 binding by direct or allo-
steric mechanisms.
The current results also provide mechanistic insight into
GPR124 regulation of canonical RECK/WNT7 signaling. A signal-
osome model proposes that the GPR124 ICD associates with
Dishevelled (DVL) that bridges to FZDs, while the GPR124 ECD
recruits WNT7 via RECK (Eubelen et al., 2018). Our study sup-
ports an essential role of the GPR124 ECD, but reveals ICD func-
tion as largely dispensable for WNT7 signaling, because (1) a
GPR124 DICD mutant retains strong activity in a canonical Wnt
reporter assay, (2) membrane-tethered GPR124 ECD fused to
the VEGFR2 TMD still mediates WNT7 signaling, and (3) recom-
binant soluble GPR124 ECD augments RECK/WNT7 signaling
to the same extent as full-length GPR124. Thus, GPR124 does
not appear to intrinsically transduce a canonical RECK/WNT7
signal into the cell, suggesting that GPR124/RECK act primarily
in an extracellular fashion. GPR124 ICD deletion leaving 28 resid-
ual membrane-proximal amino acids has been reported to
completely abrogateGPR124 functionbypreventingDVL recruit-
ment (Eubelen et al., 2018); we deleted a larger portion of the
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GPR124 ICD, leaving only 10 membrane-proximal amino acids
with the resultant protein being robustly active in canonical Wnt
reporter assays. Cell surface proximity ligation studies suggest
that extracellular GPR124 activity modulates RECK/WNT7 bind-
ing (Eubelen et al., 2018). Our biochemical studies do not indicate
GPR124 regulation of soluble RECK:WNT7A complex formation
in CM or cell surface RECK:WNT7A association. Overexpressed
GPR124 upregulated RECK cell surface expression, which could
Figure 4. RECK Promotes FZD8:WNT7A Complex Formation
(A) GPR124, RECK, and WNT7A form a ternary complex. HEK293 RECK/ (control) or HEK293 RECK/ WNT7A cells were cultured in medium supplemented
with the indicated proteins (50 nM) for 72 hr. CM were harvested and subjected to Protein A pull-down.
(B) GPR124 does not regulate cell surface RECK:WNT7A complex formation. Cells were transfected with indicated expression constructs for 48 hr. SNAP tags
were specifically biotinylated (bSNAP) and cell surface proteins cross-linked in situ byDTSSP (100 mM). Cells were lysed, subjected to streptavidin pull-down, and
cross-links reversed. WCL, whole cell lysate. b2AR, b2-adrenergic receptor.
(C) FZD/GPR124/RECK/WNT7A quaternary complex formation is not detectable in vitro. sRECK-His:WNT7A complex was purified from HEK293 RECK/
WNT7ACM (72 hr, 100 nM sRECK-His) using Ni-NTA agarose. Indicated purified proteins/sRECK:WNT7A complex (1 mM each) were allowed to form complexes
and subjected to Protein A pull-down. Faint non-specific sRECK binding in all lanes.
(D) FZD8 elutes WNT7A from RECK. sRECK-Fc:WNT7A complex was isolated from HEK293 RECK/ WNT7A CM (72 hr, 100 nM sRECK-Fc) by Protein A
agarose. Beads were incubated with 0.1, 1, or 10 mM sFZD4/sFZD8 protein (wedges) or glycine, pH 2.9 for 1 hr (eluate 1) and then with 1% SDS (eluate 2).
(E) WNT7A binding to RECK and FZD8 is mutually exclusive. HEK293 RECK/ WNT7A cells were cultured in medium supplemented with indicated proteins
(25 nM) for 72 hr. CM were subjected to sequential Ni-NTA agarose (1st) and Protein A agarose (2nd) pull-downs.
(F) RECK dose-dependently enhances FZD8:WNT7A complex formation. HEK293 RECK/ WNT7A cells were cultured in medium supplemented with sFZD8-
His and sRECK-Fc proteins as indicated for 72 hr. CM were subjected to Ni-NTA pull-down.
(G) Model of RECK/GPR124-regulated canonical WNT7 signaling. GPR124 ECD binding to RECK strongly enhances RECK/WNT7-induced canonical Wnt
signaling by an extracellular mechanism that does not involve intrinsic GPR124 signal transduction or regulation of RECK:WNT7 complex formation. The RECK
cystine knot motifs (blue) and cysteine-rich domain (purple) mediate binding of RECK:GPR124 to WNT7, stabilizing WNT7 in its active, monomeric, hydrophobic
form. Free WNT7 rapidly converts into an inactive, aggregated, hydrophilic state. The GPR124:RECK complex acts as a stabilizing receptor for WNT7 increasing
bioavailability of active, monomeric cell surfaceWNT7. GPR124:RECK-boundWNT7 is eventually transferred to FZD and LRP5/6 co-receptors by transient direct
or indirect interactions. Alternatively, GPR124/RECK/WNT7 could form a stable multi-protein receptor complex with FZD/LRP5/6.
All western blots (WB) were performed under reducing conditions. All data are representative of at least two independent experiments with similar results. CM,
conditioned medium; s, soluble ECD; Fc, IgG Fc fragment.
See also Figure S5.
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indirectly increase cell surface RECK:WNT7 complexes, but
Gpr124D/ primary brain endothelial cells do not exhibit a corre-
sponding cell surface RECK decrease. Soluble GPR124 ECD
structure-function analysis implicates the GPR124 LRR/GAIN
and to a lesser extent HRM domains in RECK/WNT7 signaling,
correlating with their requirement in GPR124:RECK complex
formation, agreeing with full-length receptor mutants (Cho
et al., 2017), but further indicating GAIN domain participation.
CNS endothelium expresses mRNAs for at least three canon-
ical Fzds (Fzd4 and to a lesser degree Fzd1 and Fzd8) and non-
canonical Fzd6 (Daneman et al., 2009; Zhang et al., 2014) that
might redundantly mediate canonical Wnt signaling. Fzd4, the
predominant Fzd in CNS endothelium, bound WNT7A with low
affinity. In contrast, FZD8 robustly bound WNT7A. While
GPR124 and/or RECK did not enhance FZD4:WNT7 association,
RECK drastically enhanced FZD8:WNT7 binding, potentially
reflecting mechanistic differences between FZD4 and FZD8 or
technical limitations of our assays. On the other hand, FZD4
might preferentially bind Norrin (Wang et al., 2012), while other
FZDs such as FZD1 and FZD8 could potentially possess tropism
for WNT7. However, our results by no means exclude WNT7
binding to FZD4 by yet undescribed mechanisms.
Crucially, RECK binding stabilizes WNT7A in its active, mono-
meric, hydrophobic state. The obligate palmitoylation of Wnt
proteins underlies their hydrophobicity, FZD binding, and activity
(Janda et al., 2012; Kakugawa et al., 2015; Zhang et al., 2012).
Unlike WNT3A, active, monomeric, hydrophobic WNT7A is
very short-lived and rapidly converts into an inactive, aggre-
gated, hydrophilic form after secretion, unless bound by RECK
or other receptors. Wnt-inactivating enzymes convert active
WNT3A to an inactive, aggregated, hydrophilic protein (Kaku-
gawa et al., 2015; Zhang et al., 2012). However, the short half-
life of active, hydrophobic WNT7A is intrinsic to this protein,
since purified hydrophobic WNT7A eluted from RECK or FZD8
rapidly became hydrophilic, potentially underlying short-range
action of WNT7A in vivo.
Immunofluorescence co-localization (Eubelen et al., 2018) or
binding of RECK/GPR124 ECD fragments to GPR124/RECK/
WNT7/FZD/LRP-transfected cells (Cho et al., 2017) have sug-
gested WNT7-induced formation of FZD/LRP/GPR124/RECK
multi-receptor complexes or signalosomes. The current
biochemical studies with recombinant ECDs did not reveal
multi-protein receptor complex formation, but might not have
been sufficiently sensitive to detect transient complexes. Cell
surface RECK:WNT7 interaction may be similarly short-lived,
given the ultimate preference ofWNT7 for FZD. The presentation
of WNT7 to FZD by RECK in a manner favoring FZD:WNT7 com-
plex formation could link GPR124/RECK/WNT7 and FZD/WNT7/
LRP signaling, with GPR124:RECK stabilizing and presenting
cell surface WNT7, thus directly or indirectly promoting FZD/
WNT7/LRP association (Figure 4G).
Overall, our identification of RECK as a GPR124-associated
WNT7 receptor that forms a 1:1 complex with active, mono-
meric, hydrophobic WNT7 extends the known structural and
functional diversity of Wnt receptors. Conceivably, RECK could
also modulate WNT7 action in non-vascular and non-CNS
compartments. Stabilization of specific Wnts by accessory re-
ceptors, as exemplified by RECK and WNT7, may be generally
utilized as a strategy broadly employed for multi-tiered control
of Wnt signaling as well as other growth factor pathways.
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KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
aFLAG M2 agarose Sigma-Aldrich Cat# A2220; RRID: AB_10063035
aFLAG M2-HRP Sigma-Aldrich Cat# A8592; RRID: AB_439702
Rabbit aFLAG Sigma-Aldrich Cat# F7425; RRID: AB_439687
aHA tag agarose Sigma-Aldrich Cat# A2095; RRID: AB_257974
Rabbit aRECK Cell Signaling Technology Cat# 3433; RRID: AB_2238311
Rabbit aWNT3A Cell Signaling Technology Cat# 2721; RRID: AB_2215411
Rabbit aN-cadherin ThermoFisher Scientific Cat# PA1-20359; RRID: AB_2077427
Mouse ab-actin Santa Cruz Biotechnology Cat# sc-47778; RRID: AB_626632
Goat aVE-cadherin Santa Cruz Biotechnology Cat# sc-6458; RRID: AB_2077955
Rabbit aWNT7A abcam Cat# ab100792; RRID: AB_10858110
aWNT7A agarose This paper N/A
Rabbit aWNT7B abcam Cat# ab155313
Mouse ab-catenin BD Biosciences Cat# 610153; RRID: AB_397554
Rabbit aGSK3b Cell Signaling Technology Cat# 9315; RRID: AB_490890
Mouse aHis tag ThermoFisher Scientific Cat# MA1-21315; RRID: AB_557403
Rabbit aSNAP tag New England Biolabs Cat# P9310; RRID: AB_10631145
Goat aHuman Fc-HRP Jackson ImmunoResearch Cat# 109-035-098; RRID: AB_2337586
Goat aMouse Fc-HRP Jackson ImmunoResearch Cat# 115-035-071; RRID: AB_2338506
Donkey aRabbit IgG-HRP Jackson ImmunoResearch Cat# 711-035-152; RRID: AB_10015282
Donkey aMouse IgG-HRP Jackson ImmunoResearch Cat# 715-035-150; RRID: AB_2340770
Donkey aGoat IgG-HRP Jackson ImmunoResearch Cat# 705-035-003; RRID: AB_2340390
Goat aRabbit IgG-Alexa Fluor 488 Jackson ImmunoResearch Cat# 111-545-003; RRID: AB_2338046
Rabbit aMouse GPR124 extracellular domain This paper N/A
Rabbit aGPR124 agarose This paper N/A
Rabbit IgG agarose This paper N/A
Rabbit aHuman GPR124 intracellular domain This paper N/A
Bacterial and Virus Strains
E. coli BL21(DE3) Agilent Technologies Cat# 200131
Ad sFzd8-Fc Daneman et al., 2009 N/A
Ad HA-Dkk1 Kuhnert et al., 2004 N/A
Ad sVegfr2-Fc (Ad Flk1-Fc) Kuo et al., 2001 N/A
Ad sGPR124-Fc This paper N/A
Ad sRECK-Fc This paper N/A
Chemicals, Peptides, and Recombinant Proteins
4-hydroxytamoxifen Sigma-Aldrich Cat# T176
SNAP-Biotin New England Biolabs Cat# S9110S
GM6001 Enzo Life Sciences Cat# BML-EI300
DSS ThermoFisher Scientific Cat# 21655
DSP ThermoFisher Scientific Cat# 22586
DTSSP ThermoFisher Scientific Cat# 21578
BS3 ThermoFisher Scientific Cat# 21580
Human sGPR124 (sTEM5) Vallon and Essler, 2006 N/A
Human sGPR124-Fc This paper N/A
(Continued on next page)
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REAGENT or RESOURCE SOURCE IDENTIFIER
Human sRECK This paper N/A
Human sRECK-Fc This paper N/A
Human sFZD4 Janda et al., 2012 N/A
Mouse sFZD4-Fc R&D Systems Cat# 194-FZ
Mouse sFZD8 Janda et al., 2012 N/A
Mouse sFZD8-Fc Daneman et al., 2009 N/A
Mouse sLRP5 R&D Systems Cat# 7344-LR
Mouse sLRP6 R&D Systems Cat# 2960-LR
Mouse sVEGFR2-Fc (FLK1-Fc) Kuo et al., 2001 N/A
Mouse sEPHB4-Fc R&D Systems Cat# 446-B4
Mouse HA-DKK1 Kuhnert et al., 2004 N/A
Mouse WNT3A PeproTech Cat# 315-20
Human WNT7A PeproTech Cat# 120-31
Critical Commercial Assays
Dual-luciferase reporter assay system Promega Cat# E1980
Experimental Models: Cell Lines
Human: HEK293 cells ATCC Cat# CRL-1573
Human: HEK293 RECK/ cells This paper N/A
Human: HEK293 RECK/ WNT3A cells This paper N/A
Human: HEK293 RECK/ WNT7A cells This paper N/A
Human: HEK293 RECK/ WNT7B cells This paper N/A
Human: HEK293T cells ATCC Cat# CRL-3216
Human: HEK293T FZD1/2/4/5/7/8 KO cells Voloshanenko et al., 2017 N/A
Human: Expi293F cells ThermoFisher Scientific Cat# A14527
Experimental Models: Organisms/Strains
Rat: Sprague Dawley Charles River Laboratories Cat# 001
Mouse: Gpr124: B6.129S-Gpr124tm1Cjku Kuhnert et al., 2010 N/A
Mouse: Gpr124fl: B6.129S-Gpr124flex1 Kuhnert et al., 2010 N/A
Mouse: Cdh5-CreER: C57BL/6-Tg(Cdh5-cre/ERT2)1Rha Ralf Adams; Wang et al., 2010 N/A
Oligonucleotides
hRECK sgRNA #1: GAGCAGCGCACCTCGCAGAG This paper N/A
hRECK sgRNA #2: CACATACATCACGGCACATT This paper N/A
Recombinant DNA
pFLAG-MAC-GPR124 ICD (aa 1067 – 1338, human) This paper N/A
p3xFLAG-CMV-9-GPR124 (aa 34 - 1338, human) Vallon and Essler, 2006 N/A
p3xFLAG-CMV-9-GPR124 DECD (Daa 34 – 770) This paper N/A
p3xFLAG-CMV-9-GPR124 DICD (Daa 1078 – 1338) This paper N/A
p3xFLAG-CMV-9-sGPR124-His (aa 34 - 755, human) Vallon and Essler, 2006 N/A
p3xFLAG-CMV-9-sGPR124 DLRR-His (Daa 34 - 247) This paper N/A
p3xFLAG-CMV-9-sGPR124 DHRM-His (Daa 349 - 426) This paper N/A
p3xFLAG-CMV-9-sGPR124 DGAIN-His (Daa 427 - 755) This paper N/A
p3xFLAG-CMV-9-sGPR124-VEGFR2 TMD-FKBP (mbECD) This paper N/A
pAd5DE1DE3-Igk SP-sGPR124-Fc This paper N/A
Human RECK cDNA GE Healthcare Dharmacon (Incyte) Clone# LIFESEQ4097514
p3xFLAG-CMV-9-RECK (aa 23 – 971, human) This paper N/A
p3xFLAG-CMV-9-RECK DCK (Daa 37 - 338) This paper N/A
p3xFLAG-CMV-9-RECK DCRD (Daa 343 - 476) This paper N/A
p3xFLAG-CMV-9-RECK DKazal1 (Daa 632 - 677) This paper N/A
(Continued on next page)
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CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Calvin J.
Kuo (cjkuo@stanford.edu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell lines and maintenance
HEK293/HEK293T cells and sub cell lines were maintained in DMEM supplemented with 10% FBS and 1x penicillin/streptomycin
(ThermoFisher Scientific) at 37C and 8% CO2. HEK293T FZD1/2/4/5/7/8 KO cells were provided by M. Boutros and O. Volosha-
nenko (Voloshanenko et al., 2017). Expi293F cells were obtained from ThermoFisher Scientific andmaintained in Expi293 Expression
Medium according to the manufacturer’s recommendations.
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
p3xFLAG-CMV-9-RECK DKazal2 (Daa 708 - 750) This paper N/A
p3xFLAG-CMV-9-RECK DKazal3 (Daa 753 - 787) This paper N/A
p3xFLAG-CMV-9-RECK DEGF2 (Daa 676 - 709) This paper N/A
pcDNA3.1-Igk SP-sRECK-Fc (aa 23 - 942, human) This paper N/A
pcDNA3.1-Igk SP-sRECK-Fc DCK (Daa 37 - 338) This paper N/A
pcDNA3.1-Igk SP-sRECK-Fc DCRD (Daa 343 - 476) This paper N/A
pcDNA3.1-Igk SP-sRECK-His This paper N/A
pAd5DE1DE3-Igk SP-sRECK-Fc This paper N/A
p3xFLAG-CMV-9-sRECK-VEGFR2 TMD-FKBP (GPI > TMD) This paper N/A
pcDNA-WNT3A (human) Najdi et al., 2012 Addgene plasmid #35908
pcDNA-WNT7A (human) Najdi et al., 2012 Addgene plasmid #35914
pcDNA-WNT7B (human) Najdi et al., 2012 Addgene plasmid #35915
pRK5-mFzd4 Yu et al., 2012 Addgene plasmid #42256
pRK5-Lrp5 Aaron Hsueh; Yu et al., 2012 N/A
pSNAPf-ADRb2 (human) New England Biolabs Cat# N9184
pSNAPf New England Biolabs Cat# N9183S
p3xFLAG-CMV-9-SNAPf-GPR124 This paper N/A
p3xFLAG-CMV-9-SNAPf-RECK This paper N/A
pRK5-SNAPf-mFzd4 This paper N/A
p3xFLAG-CMV-9-Fzd8 (mouse) This paper N/A
pGL4.49[luc2P/TCF-LEF/Hygro] (STF reporter) Promega Cat# E4611
pRL-TK (Renilla luciferase reporter) Promega Cat# E2241
pLentiCRISPR Sanjana et al., 2014 Addgene plasmid #52961
Software and Algorithms
xVis Crosslink Analysis Webserver http://xvis.genzentrum.lmu.de/
login.php; Grimm et al., 2015
N/A
CRISPR design tool http://crispr.mit.edu N/A
Other
Bovine fibronectin Sigma-Aldrich Cat# F1141
Normal donkey serum Jackson ImmunoResearch Cat# 017-000-121
Normal goat serum Jackson ImmunoResearch Cat# 005-000-121
Streptavidin agarose ThermoFisher Scientific Cat# 20347
Protein A agarose SeraCare Cat# 5710-0005
Ni-NTA agarose QIAGEN Cat# 30210
Superose 6 Prep Grade GE Life Sciences Cat# 17048901
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Rodent strains, maintenance, and breeding
Rodents were housed in 12-hour light and dark cycles in a pathogen-free animal facility. All animal experiments were performed in
accordance with the National Institutes of Health guidelines for use and care of live animals and were approved by the Institutional
Animal Care and Use Committee at Stanford University. Male Sprague Dawley rats were obtained from Charles River Laboratories.
The mouse Gpr124 KO (Gpr124) and floxed exon 1 (Gpr124fl) alleles were generated and genotyped as previously described (Kuh-
nert et al., 2010). Transgenic mice expressing the CreER(T2) fusion protein under control of a VE-cadherin promoter (Cdh5-CreER)
were obtained from Ralf Adams and genotyped as previously described (Wang et al., 2010). Gpr124fl/; Cdh5-CreER mice were
obtained by crossing Gpr124fl/fl with Gpr124+/; Cdh5-CreER mice. All mutant mice had been backcrossed to the C57BL/6 strain.
E12.5 mouse embryos were obtained by setting up wild-type breeding pairs for timed pregnancies. The morning a female was found
with a vaginal plug was considered E0.5. At E12.5 pregnant females were sacrificed and embryos dissected.
Primary brain endothelial cells
Primary brain endothelial cells were isolated fromwild-type andGpr124fl/; Cdh5-CreERmice as previously described (Perrie`re et al.,
2005) and cultured in 6-well plates until confluent (7d). Cell culture medium was supplemented with 1 mM 4-hydroxytamoxifen for
the first three days to induce conditional KO of Gpr124.
METHOD DETAILS
Generation of HEK293 RECK/ cells
TheRECK gene in HEK293 cells was disrupted usingCRISPR/Cas9. The Cas9 coding sequence frompLentiCRISPR, a gift from Feng
Zhang (Addgene plasmid #52961) (Sanjana et al., 2014) was fused to the T2A peptide andGFP coding sequences and sub cloned into
the adenoviral shuttle vector pAdd2 (pAdd2-Cas9-T2A-GFP). The pLentiCRISPR vector was modified by replacing the Cas9 insert
with mCherry yielding the construct pLenti-sgRNA-mCherry-P2A-Puro. Human RECK exon 1 without 50 UTR was used as input
sequence to identify RECK-specific single guide (sg) RNAs using the Zhang lab’s web tool (http://crispr.mit.edu). The two highest
scored sgRNAs (sgRECK#1and #2)were synthesized as double strandedDNAswith BsmBI-compatible 50 overhangs by theStanford
Protein and Nucleic Acid (PAN) core facility. sgRECK#1 (sense: caccgGAGCAGCGCACCTCGCAGAG, antisense: aaacCTCTG
CGAGGTGCGCTGCTCc) and sgRECK#2 (sense: caccgCACATACATCACGGCACATT, antisense: aaacAATGTGCCGTGATGTAT
GTGc) were cloned into pLenti-sgRNA-Cherry-P2A-Puro. HEK293 cells were seeded into 6-well plates, incubated for 24h, and trans-
fectedwith 3 mgCas9 and/or 3 mg sgRECK#1 or sgRECK#2. 72h after transfection RECK expression levels were analyzed by western
blotting. Cas9/sgRECK#1 and Cas9/sgRECK#2 co-transfected cells showed reduced RECK expression compared to Cas9,
sgRECK#1, and #2 only transfected cells (data not shown). Since sgRECK#1 suppressed RECK expression more efficiently than
sgRECK#2, single clones were isolated from Cas9/sgRECK#1 co-transfected HEK293 cells after 48h by limiting dilution cloning in
a 96-well plate. Single cloneswere expanded in 6-well plates and screened for complete loss (homozygous deletion) ofRECK expres-
sion by western blotting. Clone number 13 (HEK293 RECK/ cells) was further expanded and used for subsequent experiments.
Transient and stable transfection of cells
HEK293 and HEK293T cells were transfected using the calcium phosphate precipitation method as described (Graham and van
der Eb, 1973). 24h before transfection 5 3 106 or 9 3 105 cells were seeded into 10 cm dishes or 6-well plate wells, respectively.
Cells seeded into 10 cm dishes were transfected with 34 mg total DNA and cells seeded into 6-well plate wells with 6 mg total
DNA. pBluescript was used as carrier DNA to keep DNA amounts constant. For stable transfections HEK293 cells were transfected
with 6 mg expression plasmid (containing a neomycin resistance cassette) per well in 6-well plates. 48h after transfection cells were
transferred to T75 flasks and selected for stable transfectants using 600 mg/ml geneticin (Chem-Impex International, Wood Dale, IL)
for two weeks. Pools of stably transfected HEK293 cell clones were maintained in DMEM supplemented with 10% FBS and
600 mg/ml geneticin. Expi293F cells were transfected in 125 mL or 500 mL Erlenmeyer cell culture flasks using the ExpiFectamine
293 Transfection Kit (ThermoFisher Scientific) according to the manufacturer’s protocol.
Generation of GPR124 antibodies
Anti-mouse GPR124 ECD antibody
Anti-mouse GPR124 ECD antiserum was generated by immunizing rabbits (Rockland Immunochemicals, Pottstown, PA) with
recombinant mouse GPR124 ECD, which had been cloned, expressed, and purified from stably transfected HEK293 cell conditioned
medium as previously described (Vallon et al., 2010). Polyclonal antibody was purified from antiserum of best responder by antigen
affinity chromatography.
Anti-human GPR124 ICD antibody
The humanGPR124 ICD (aa 1067 – 1338, UniProtKB #Q96PE1) was cloned into the pFLAG-MACbacterial expression vector (Sigma-
Aldrich), expressed in E. coli BL21(DE3), and purified from E. coli lysates using aFLAG M2 agarose. Anti-human GPR124 ICD anti-
serum was generated by immunizing a rabbit (pAb productions, Hebertshausen, Germany) with the recombinant protein. Polyclonal
antibody was purified from antiserum by antigen affinity chromatography.
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Covalent coupling of antibodies to agarose beads
Rabbit anti-mouse GPR124 ECD antibody (500 mg antibody/100 ml beads), ChromPure rabbit IgG (Jackson ImmunoResearch
#011-000-003, 500 mg antibody/100 ml beads), or carrier-free anti-WNT7A antibody (abcam #ab100792, 100 mg antibody/100 ml
beads) were covalently coupled to agarose beads using AminoLink Plus Immobilization Kit (ThermoFisher Scientific) according to
the manufacturer’s protocol.
Immunofluorescence staining
63 104 HEK293 cells per well were seeded into fibronectin-coated 8-chamber glass slides (ThermoFisher Scientific) and incubated
for 24h. Cells were transfected with 4 ng indicated expression construct for 48h and fixed with 4% formaldehyde in PBS for 15 min.
Fixed cells were washed three times with PBS (5 min each), blocked with 5% normal goat serum in PBS for 1h, and incubated
with rabbit aFLAG antibody (Sigma-Aldrich, 10 mg/ml) in PBS/1%BSA for 1h. Cells were washed as before and incubated with Alexa
Fluor 488-conjugated goat anti-rabbit IgG antibody (Jackson ImmunoResearch, 1:1000) in PBS/1% BSA for 1h. Cells were washed
as before and coverslips mounted using VECTASHIELD HardSet Antifade Mounting Medium with DAPI (Vector Laboratories,
Burlingame, CA). Stained cells were imaged using a fluorescence microscope with Apotome (Zeiss, Oberkochen, Germany).
Western blot analysis
Western blot analyses were performed using standardmethods. Briefly, samples were supplemented (or eluted from agarose beads)
with NuPAGE LDS Sample Buffer (ThermoFisher Scientific). Unless indicated otherwise samples were supplemented with 50 mM
DTT (reducing conditions). NuPAGE Novex 4%–12% Bis-Tris Gels (ThermoFisher Scientific) were used for SDS-PAGE.
PageRuler Plus Prestained Protein Ladder (ThermoFisher Scientific) was used as molecular weight marker. Separated proteins
were transferred to PVDF membranes (EMD Millipore, Hayward, CA) and membranes were blocked with 5% non-fat dry milk
in TBS/0.1 Tween 20 (TBST/milk). Membranes were incubated with primary antibodies diluted in TBST/milk or TBST/5% BSA
(0.1 – 1 mg/ml). HRP-conjugated primary or secondary antibodies were diluted 1:10000 in TBST/milk. After antibody incubations
(1h – overnight) blots were washed 3x with TBST for 10 min each. Bound antibodies were visualized using SuperSignal West
Pico/Femto Chemoluminescent Substrates (ThermoFisher Scientific) and exposure of AccuRay Blue X-Ray Films (E&K Scientific).
GPR124 affinity chromatography
Brains from six 3-month-old Sprague Dawley rats (Charles River Laboratories, Wilmington, MA) were dissected and meninges were
removed using cotton swabs. Brains were washed once with ice-cold PBS and homogenized on ice in 10 mL PBS per brain using a
15 mL Dounce homogenizer. Homogenates were pooled, pelleted, and resuspended in 200 mL ice-cold PBS + 20% BSA. Suspen-
sion was centrifuged at 1000 3 g, 4C for 25 min and myelin top layer and supernatant were aspirated. Pellet was resuspended in
10mL ice-cold PBS and passed through a 70 mmcell strainer. Strainer was washed three timeswith ice-cold PBS and inverted onto a
10 cm Petri dish. Blood vessels were rinsed off strainer using ice-cold PBS, transferred to a 50 mL conical tube, and pelleted. Blood
vessels were split into two equal aliquots. One aliquot was resuspended in 10 mL ice-cold PBS/0.1 mM dithiobis(succinimidyl pro-
pionate) (DSP)/0.5% DMSO and one in 10 mL ice-cold PBS/0.5% DMSO only and incubated at 4C under constant rotation for 2h.
Blood vessels were pelleted, resuspended in 10 mL ice-cold TBS, and incubated at 4C under constant rotation for 15 min. Blood
vessels were washed once with ice-cold TBS, pelleted, weighed, and lysed in RIPA buffer (TBS, 1% Triton X-100, 0.5% sodium de-
oxycholate, 0.1%SDS, cOmplete Protease Inhibitor Cocktail [Roche, Indianapolis, IN]) at 1mL lysis buffer per 100mg tissue. Lysates
were incubated on ice for 30 min vortexing occasionally. Lysates were cleared by centrifugation and incubated over night at 4C un-
der constant rotation with 10 ml anti-mouse GPR124 ECD or rabbit IgG agarose (5 mg antibody/ml beads). Agarose beads were trans-
ferred to mini spin columns (Thermo Fisher Scientific) and centrifuged at 3000 3 g for 30 s. Flow throughs (unbound fractions) were
saved. Beads were washed three times for 5 min with 0.5 mL RIPA buffer at 4C under constant rotation. Washing was repeated as
above with TBS/1% Triton X-100/1MNaCl and thenwith 0.1M sodium acetate, pH 5.3/1%Triton X-100. Bound proteins were eluted
by incubating beads with 50 ml 0.1 M glycine/HCl, pH 2.0/1% Triton X-100 at 4C under constant rotation for 5 min. Eluates were
neutralized by adding 3.5 ml 1.5 M Tris/HCl, pH 8.8 and bound and unbound fractions were analyzed by SDS-PAGE followed by silver
staining or western blotting. Silver-stained bands of proteins that co-purified with GPR124 upon in situ protein cross-linking were
excised from gel and submitted to the Stanford University Mass Spectrometry (SUMS) core facility for identification.
Generation of conditioned media
53 105 HEK293 RECK/ cells ± stable transfection withWNT3A,WNT7A, orWNT7B were seeded per well in 6-well plates. Where
indicated, medium (DMEM + 10% FBS) was supplemented with recombinant protein and conditioned for 48h – 96h. Conditioned
media were harvested and cleared by centrifugation.
Pull-down assays
Using conditioned media
Conditioned media (1 mL each) were supplemented with 100 ml 10xTBS (Protein A pull-down) or 10xPBS (Ni-NTA pull-down). 75 ml
samples (inputs) were saved and remaining conditioned media were incubated with 10 ml Protein A or Ni-NTA agarose for 1h at room
temperature under constant rotation. Agarose beads were washed six times with 2xTBS (Protein A) or 2xPBS/5 mM imidazole
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(Ni-NTA) and bound proteins were eluted by incubating beads with SDS-PAGE sample buffer for 10 min at room temperature under
constant rotation. Eluates (pull-downs) and inputs were analyzed by western blotting.
Using recombinant protein mixtures
Recombinant proteins were added to TBS/0.1% Triton X-100 at indicated concentrations and incubated for 1h at room temperature
or overnight at 4C. Input samples were saved and remaining mixtures were incubated with 10 ml Protein A agarose for 1h at room
temperature under constant rotation. Agarose beads were washed six times with TBS/0.1% Triton X-100 and bound proteins were
eluted with reducing SDS-PAGE sample buffer for 10 min at room temperature. Inputs and eluates (pull-downs) were analyzed by
western blotting.
Using whole cell lysates
HEK293RECK/WNT7A/WNT3A cells seeded into 6-well plates were transfected with the indicated expression construct(s) and/or
empty vector (600 ng expression vector(s) + 5.4 mg pBluescript). 48h after transfection SNAP tags were specifically auto-biotinylated
(bSNAP) by incubating cells with 5 mM SNAP-Biotin substrate (New England Biolabs) for 30 min. Cells were washed twice with ice-
cold HBS++ (20 mM HEPES, pH 7.4, 150 mM NaCl, 1 mM CaCl2, 0.5 mMMgCl2) and incubated with 0.1 mM DTSSP cross-linker in
HBS++ on ice for 2h. Unreacted cross-linker was quenched by adding 50 mM Tris/HCl, pH 7.4 for 15 min. Cells were scraped into
150 ml RIPA lysis buffer (TBS, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, cOmplete ULTRA Protease Inhibitor Cocktail
[Roche], PhosSTOP Phosphatase Inhibitor Cocktail [Roche]) and incubated on ice for 30 min vortexing occasionally. Lysates were
cleared by centrifugation and split 1:1 into input and pull-down aliquots. 10 ml streptavidin agarose was added to pull-down aliquots
and incubated at 4Cunder constant rotation for 1h. Beadswerewashed six timeswith TBS/2%SDS and bound proteins were eluted
by incubating beads in reducing SDS-PAGE sample buffer supplemented with 3 mM biotin (Sigma) at 95C for 10 min. Whole cell
lysate inputs and streptavidin pull-downs were analyzed by western blotting.
Expression constructs and molecular cloning
All deletionmutantswere generated using theQuikChange LightningSite-directedMutagenesisKit (Agilent Technologies, SantaClara,
CA). Human GPR124 (UniProtKB #Q96PE1) lacking the endogenous signal peptide (aa 34 - 1338) was cloned into the mammalian
expression vector p3xFLAG-CMV-9 (Sigma-Aldrich) as previously described (Vallon and Essler, 2006). ECD (Daa 34 - 770) and ICD
(Daa 1078 - 1338) deletionmutants of GPR124were cloned using p3xFLAG-CMV-9-GPR124 as template. C-terminally His-tagged hu-
man GPR124 ECD (sGPR124, UniProtKB #Q96PE1, aa 34 – 755 + DGGGSHHHHHH) was cloned into p3xFLAG-CMV-9 as previously
described (VallonandEssler, 2006). Subdomaindeletionmutantsof theGPR124ECD,DLRR (Daa34 - 247),DHRM(Daa349 - 426), and
DGAIN (Daa 427 - 755) were cloned using p3xFLAG-CMV-9-sGPR124 as template. Human RECK (UniProtKB #O95980) lacking
the endogenous signal peptide (aa 23 – 971) was amplified by PCR from a cDNA clone (Incyte cDNA clone #LIFESEQ4097514, GE
Healthcare Dharmacon, Lafayette, CO) and cloned into p3xFLAG-CMV-9. sGPR124-Fc and sRECK-Fc expression constructs
were generated by fusing the mouse Igk signal peptide (aa 1 – 21) with human GPR124 ECD (aa 34 – 755) / human RECK DGPI
(aa 23 – 942) and the Fc fragment of mouse IgG2a (aa 237 - 469). Fusion constructs were cloned into the E1 region of recombinant
adenovirus type 5 (E1- and E3-deleted, replication deficient) and into pcDNA3.1(+) (Thermo Fisher Scientific). Adenoviral particles
weregeneratedby transfectingHEK293cellswith linearizedadenoviral vectors aspreviouslydescribed (Yanet al., 2017). Adenoviruses
encoding sFzd8-Fc, HA-Dkk1, and sVegfr2-Fc had been generated previously (Daneman et al., 2009; Kuhnert et al., 2004; Kuo et al.,
2001). Untagged human Wnt expression constructs pcDNA-WNT3A, -WNT7A, and -WNT7B were gifts from Marian Waterman
(Addgene plasmids #35908, #35914, and #35915) (Najdi et al., 2012). Domain deletion mutants of RECK, DCK (Daa 37 - 338), DCRD
(Daa 343 - 476), DKazal1 (Daa 632 - 677), DKazal2 (Daa 708 - 750), DKazal3 (Daa 753 - 787), and DEGF2 (Daa 676 - 709) were cloned
usingpcDNA3.1-sRECK-Fc andp3xFLAG-CMV-9-RECKas templates. AC-terminally His-tagged soluble RECKexpression construct
(sRECK-His) was generated by inserting a His6 tag + stop codon into pcDNA3.1-sRECK-Fc immediately after the sRECK coding
sequence using the QuikChange Lightning Site-directedMutagenesis Kit (Agilent Technologies). GPR124mbECD (membrane-bound
ECD) and RECK GPI > TMD constructs were cloned by fusing the human VEGFR2 TMD (UniProtKB #P35968, aa 763 - 790) to human
FKBP1A (UniProtKB #P62942, aa 2 – 108, F36Vmutation) and a stop codon. The VEGFR2 TMD-FKBP1A-stop fusionwas inserted into
p3xFLAG-CMV-9-sGPR124between the spacer (DGGGS)and theHis tagand intop3xFLAG-CMV-9-RECKbetweenaa942and943of
RECKbyGibsonassembly cloning. The sGPR124-VEGFR2TMD-FKBP1A fusionconstruct (GPR124mbECD)mediatedRECK/WNT7-
inducedSTF activationwithout FKBP ligands as shown, but STF activationwas increased two-fold upon addition of a dimerizing FKBP
ligand (data not shown). Mouse Fzd4 expression construct pRK5-mFzd4 was a gift from Chris Garcia and Jeremy Nathans (Addgene
plasmid #42256) (Yu et al., 2012). Mouse Lrp5 expression construct pRK5-Lrp5 was a gift from Aaron Hsueh (Yu et al., 2012).
N-terminally SNAP-tagged expression constructs were cloned by inserting the SNAP tag (aa 1 – 182, pSNAPf, New England Biolabs)
in frame intop3xFLAG-CMV-9-GPR124andp3xFLAG-CMV-9-RECK (between the 3xFLAG tagand theGPR124/RECK insert) and into
pRK5-mFzd4 (between the signal peptide and the mature protein) using Gibson assembly. N-terminally SNAP-tagged b2-adrenergic
receptor (pSNAPf-ADRb2) was from New England Biolabs. The mouse Fzd8 coding sequence (UniProtKB #Q61091) without signal
peptide (aa 28 – 685) was synthesized by Integrated DNA Technologies and cloned into p3xFLAG-CMV-9.
Expression and purification of recombinant proteins
Recombinant sGPR124-Fc, sFZD8-Fc, HA-DKK1, and sVEGFR2-Fc were expressed in HEK293 cells transduced with the corre-
sponding recombinant adenovirus at an MOI of 1. Recombinant sGPR124 and sGPR124 subdomain deletion mutants were
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expressed in HEK293 cells stably transfected with p3xFLAG-CMV-9-sGPR124-His (wild-type or subdomain deletion). Cells were
seeded into T225 flasks and cultured until confluent. Culture mediumwas replaced with serum-free DMEM (ThermoFisher Scientific)
and, unless stably transfected, cells were transduced with adenovirus at the same time. Culture medium of adenovirally transduced
HEK293 cells was conditioned until most cells showed adenoviral cytopathic effect (3 – 7 days). Culture medium of stably transfected
cells was conditioned for 7 days.Medium conditioning of stably transfected HEK293 cells was repeated twice and conditionedmedia
(CM) were pooled. Recombinant sRECK-Fc, sRECK-Fc subdomain deletion mutants, and sRECK-His proteins were expressed
in Expi293F cells transiently transfected with the corresponding pcDNA3.1 expression construct. Serum-free culture medium of
transfected Expi293F cells was conditioned for 5 days. CM were harvested and cleared by centrifugation. For purification of
3xFLAG-, HA-, and His-tagged proteins CM were concentrated 10 to 100 fold using Centricon Plus-70 centrifugal filters (MWCO
10 kDa, EMD Millipore). For purification of 3xFLAG-, HA-, and Fc-tagged proteins CM were supplemented with 1xTBS/0.1% Triton
X-100. For purification of His-tagged proteins concentrated CM were diluted 1:10 in 2xPBS/10 mM imidazole. CM were incubated
with 0.5 mL Protein A agarose (Fc-tagged proteins), 1 mL aFLAG M2 agarose (3xFLAG-tagged proteins), 1 mL aHA agarose
(HA-tagged proteins), or 100 ml Ni-NTA agarose (His-tagged proteins) for 2h at room temperature or overnight at 4C under constant
rotation or stirring. Protein A, aFLAG M2, and aHA agarose beads were recovered from CM using gravity flow columns and washed
six times with 10 volumes 4xTBS/0.1% Triton X-100 and three times with 10 volumes 1xTBS. Bound proteins were eluted with 0.1 M
glycine/HCl, pH 2.9 (Protein A agarose), pH 3.5 (aFLAG M2 agarose), or pH 2.5 (aHA agarose) and neutralized with 1 M Tris/HCl,
pH 8.5. Ni-NTA agarose beads were recovered from CM, washed five times with 10 volumes 2xPBS/20 mM imidazole, and bound
proteins were eluted with 2xPBS/250 mM imidazole. Eluates were concentrated using Amicon Ultra-4 centrifugal filters (MWCO
10 kDa, EMD Millipore) and dialyzed against PBS. Protein concentrations were determined using A280 measurements and the
calculated extinction coefficients. Protein purity and integrity was assessed by SDS-PAGE followed by Coomassie Blue staining.
Purified recombinant sEPHB4-Fc (#446-B4), sFZD4-Fc (#194-FZ), sLRP5-His (#7344-LR), and sLRP6-His (#2960-LR) were from
R&D Systems (Minneapolis, MN). Recombinant His-tagged/biotinylated human FZD4 and mouse FZD8 cysteine-rich domains
(sFZD4/sFZD8) were generated as previously described (Janda et al., 2012). Purified recombinant sFZD8-Fc was biotinylated using
Sulfo-NHS-LC-Biotin (ThermoFisher Scientific) according to the manufacturer’s protocol.
Cross-linking mass spectrometry
Purified recombinant sGPR124 and sRECK-Fc proteins were mixed (1 mM each) in PBS. The homobifunctional, amine-reactive
cross-linker DSS was dissolved in DMSO, added to the protein mixture (1 mM), and incubated at room temperature for 30 min.
Unreacted DSS was quenched by adding 50 mM Tris/HCl, pH 7.4 for 15 min. Cross-linked and control samples were separated
by SDS-PAGE followed by Coomassie Blue staining. The band corresponding to the sGPR124:sRECK-Fc complex was excised
and submitted to the SUMS core facility for cross-linking mass spectrometric analysis. Intramolecular cross-links, cross-links within
epitope tags, and cross-links with a negative log probability less than 2 are not shown. The cross-link map was generated using the
xVis Crosslink Analysis Webserver (http://xvis.genzentrum.lmu.de/login.php) (Grimm et al., 2015).
Super TOP-Flash reporter gene assay
All Super TOPflash (STF) reporter gene assays were performed as co-culture assays of HEK293 cells stably expressing the indicated
Wnt expression construct (‘‘Wnt producing population’’) and HEK293 cells transiently transfected with the STF reporter, Renilla lucif-
erase, and indicated expression constructs (‘‘Wnt reporting population’’). Wnt producing population: HEK293 or HEK293 RECK/
cells stably expressing the indicatedWnt expression construct were seeded in 96-well plates (1.53 104 cells/well) and incubated for
48h. Wnt reporting population: HEK293 or HEK293 RECK/ cells were seeded in 6-well plates, incubated for 24h, and transfected
with the indicated expression construct(s) and/or empty vector (60 ng total), 60 ng STF reporter (pGL4.49[luc2P/TCF-LEF/Hygro],
Promega, Madison, WI), 60 ng Renilla luciferase (pRL-TK, Promega), and 5.82 mg pBluescript (carrier DNA). 24h after transfection
‘‘Wnt reporting population’’ was trypsinized, resuspended in fresh medium, and added to the ‘‘Wnt producing population’’ in the
96-well plate in a 1:1 ratio. ‘‘Wnt reporting population’’ was allowed to become adherent for 2h and medium was replaced with fresh
medium supplemented or not with indicated recombinant proteins or chemical compounds. Cells were incubated for 24h and lucif-
erase activities (firefly and Renilla) were measured using the Dual-Luciferase Reporter Assay System (Promega). Firefly luciferase
(STF) activity was normalized with Renilla luciferase activity and is shown relative to the activity in control cells (‘‘non-Wnt producing
population’’ + STF/Renilla/empty vector-transfected ‘‘Wnt reporting population’’).
b-catenin stabilization assay
HEK293 RECK/ cells stably transfected or not with WNT7A or WNT3A were seeded into 10 cm dishes and transfected with 340 ng
STF reporter (pGL4.49[luc2P/TCF-LEF/Hygro], Promega), 340 ng Renilla luciferase (pRL-TK, Promega), 170 ng p3xFLAG-CMV-9-
GPR124 + 170 ng p3xFLAG-CMV-9-RECK or 340 ng empty vector, and 33 mg pBluescript. 48h after transfection cells were scraped
into 1 mL ice-cold 50 mM Tris/HCl, pH 7.4, 250 mM sucrose, 5 mM MgCl2, cOmplete protease inhibitor cocktail (Roche), and
PhosSTOP phosphatase inhibitor cocktail (Roche). 18 ml of the cell suspensions were transferred to new tubes and used for Dual-
Luciferase Reporter Assay (Promega). The remaining cells were lysed by passing the cell suspensions 20 times through a 25-gauge
needle. Cell lysates were centrifuged at 100000xg, 4C for 1h, pellets were discarded, and supernatants (cytosolic extracts) analyzed
by western blotting.
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Triton X-114 phase separation assay
Conditioned media (CM) were harvested, cleared by centrifugation, chilled on ice, supplemented with 2% Triton X-114 (from a 20%
Triton X-114/TBS stock solution), and incubated on ice for 5 min. For combined Triton X-114 phase separation and WNT7A elution
fromProtein A/sRECK-Fc/WNT7A agarose, beads were resuspended in 1mL ice-cold TBS/2%Triton X-114 and incubated on ice for
5 min. Forebrains from seven E12.5 mouse embryos were dissected on ice, weighed, and lysed in ice-cold TBS, 2% Triton X-114,
cOmplete protease inhibitor cocktail (Roche), and PhosSTOP phosphatase inhibitor cocktail (Roche) (100 mg tissue/ml lysis buffer)
by triturating with a 1 mL pipette until completely homogeneous. Lysate was incubated on ice for 30 min vortexing occasionally and
cleared by centrifugation. CM/bead suspension/forebrain lysate was layered on a cushion of 100 ml TBS/6% sucrose/0.001%Phenol
Red and incubated at 37C for 5 min (phase separation and WNT7A elution). Phases and beads were separated by centrifugation at
2000 3 g at room temperature for 5 min. Top aqueous phase was transferred to new tubes and sucrose interphase was aspirated
leaving the bottom detergent phase and/or bead pellet. Detergent phase was separated from beads and Triton X-114 concentrations
of aqueous (0.1% Triton X-114) and detergent (20% Triton X-114) phase were normalized by adding 2% Triton X-114 and 9 vol-
umes TBS, respectively. Total CM/forebrain lysate before phase separation as well as aqueous and detergent phases were analyzed
by non-reducing SDS-PAGE.
Wnt stability assay
sRECK-Fc:WNT7A, sFZD8-Fc-Biotin:WNT7A, and sFZD8-Fc-Biotin:WNT3A complexes were generated by adding the correspond-
ing Fc fusion protein (100 nM) to the culture medium of HEK293 RECK/ WNT7A/WNT3A cells. After 96h conditioned media
were harvested and protein complexes isolated using Protein A agarose (sRECK-Fc:WNT7A) or streptavidin agarose (sFZD8-Fc-
Biotin:WNT7A/WNT3A). Bound proteins were eluted using ice-cold 0.1 M glycine/HCl, pH 2.9/0.5 M NaCl/2% Triton X-114 and
immediately neutralized with Tris/HCl, pH 8.5. Low pH specifically eluted Wnt from the streptavidin/sFZD8-Fc-Biotin/Wnt beads.
sRECK-Fc co-eluted withWNT7A from the Protein A/sRECK-Fc/WNT7A beads and was specifically eliminated by three consecutive
Triton X-114 phase separations, replacing the aqueous phase with fresh TBS each time. Chilled eluates were diluted 1:100 into PBS/
10%FBS and incubated at 37C. At the indicated time points eluates were subjected to Triton X-114 phase separation and detergent
(De) and aqueous (Aq) phases analyzed by non-reducing SDS-PAGE/Western blotting.
Combined chemical cross-linking/tandem affinity purification of the sRECK:WNT7A complex
Expi293F cells were co-transfected with sRECK-His and WNT7A expression constructs at a 9:1 ratio in 125 mL Erlenmeyer cell cul-
ture flasks (30 mL Expi293 Expression Medium). 96h after transfection conditioned media (CM) were harvested, cleared by centri-
fugation, and dialyzed against 2xPBS/10 mM imidazole. 1 mL CM aliquots were incubated with 10 ml Ni-NTA agarose for 1h at
room temperature under constant rotation. Beads were washed three times with 2xPBS/20 mM imidazole and once with 1xPBS.
Non-reversible, amine-reactive cross-linker BS3 (ThermoFisher Scientific) was added to the beads at indicated concentrations in
1mL PBS and incubated for 30min at room temperature under constant rotation. Bound protein complexes were eluted and residual
BS3 cross-linker quenched by incubating beads with 100 ml 2xTBS/250 mM imidazole/0.1 Triton X-100 for 10 min. Eluates were
incubated with 10 ml anti-WNT7A agarose for 1h at room temperature under constant rotation. Beads were washed four times
with 2xTBS and bound protein complexes were eluted by incubating beads with non-reducing SDS-PAGE sample buffer for
10 min at room temperature. Eluates were supplemented with 50 mM DTT and analyzed by western blotting.
Cell surface ELISA
HEK293 RECK/ cells seeded into 6-well plates were transfected with 300 ng indicated expression construct + 300 ng Renilla lucif-
erase per well. 24h after transfection cells were seeded into two separate fibronectin-coated 96-well plates (6 3 104 cells/well) and
incubated for 24h. One plate was used to determineRenilla luciferase activities using theRenilla Luciferase Assay System (Promega).
Cells in the other plate were fixed with 4% formaldehyde in PBS for 15 min, washed three times with PBS (5 min each), and blocked
with 5% normal donkey serum in PBS for 1h. Cells were incubated with polyclonal rabbit aFLAG antibody at 1 mg/ml in PBS/1%BSA
for 1h, washed as before, and incubated with HRP-conjugated donkey anti-rabbit IgG antibody diluted 1:10000 in PBS/1% BSA for
1h. Cells were washed as before and 1-Step Ultra TMB Substrate (Thermo Fisher Scientific) was added. Reaction was stopped with
1M H2SO4 and OD410 or OD450 was measured. Background absorbance values frommock-transfected cells were subtracted from
other values. OD410/OD450 values were normalized with mean values of Renilla luciferase activities (RLU).
Cell surface protein isolation
HEK293 cells were seeded in 6-well plates and transfected with 30 ng of each expression construct and/or empty vector for 48h.
Primary brain endothelial cells were isolated from wild-type and Gpr124fl/-; Cdh5-CreER mice as previously described (Perrie`re
et al., 2005) and cultured in 6-well plates until confluent (7d). Brain endothelial cell culture medium was supplemented with 1 mM
4-Hydroxytamoxifen (Sigma) for the first three days to induce conditional KO of Gpr124. Cells were washed twice with ice-cold
HBS++ (20 mM HEPES, pH 7.4, 150 mM NaCl, 1 mM CaCl2, 0.5 mM MgCl2) and incubated with 0.4 mM Sulfo-NHS-LC-Biotin
(ThermoFisher Scientific) in HBS++ on ice for 30 min. Unreacted biotin reagent was quenched by adding 50 mM Tris/HCl, pH 7.4
for 15min. Cells were scraped into 150 ml RIPA lysis buffer (TBS, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1%SDS, cOmplete
ULTRA Protease Inhibitor Cocktail [Roche], PhosSTOP Phosphatase Inhibitor Cocktail [Roche]) and incubated on ice for 30 min
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vortexing occasionally. Lysates were cleared by centrifugation and split 1:1 into whole cell lysate and streptavidin pull-down aliquots.
10 ml streptavidin agarose were added to the pull-down aliquot and incubated at 4C under constant rotation for 1h. Unbound
supernatant (intracellular fraction) was saved, beads were washed six times with ice-cold RIPA lysis buffer, and bound proteins
(cell surface fraction) were eluted by incubating beads in reducing SDS-PAGE sample buffer supplemented with 3 mM biotin (Sigma)
at 95C for 10 min. Whole cell lysate and cell surface/intracellular fractions were analyzed by western blotting.
Gel filtration
Gel filtration column (Superose 6 prep grade [GE Life Sciences, Pittsburgh, PA], 7.5 mL bed volume, 0.6 cm inner diameter) was
calibrated using a mixture of a2-macroglubulin (720 kDa), IgG (150 kDa), and BSA (66 kDa). 100 ml WNT7A conditioned medium sup-
plemented with 10% glycerol was loaded onto column and run at 0.12 ml/min (equilibration/elution buffer: 3xTBS). 1 min fractions
were collected and proteins were precipitated with 10% trichloroacetic acid/0.02% sodium deoxycholate on ice for 1h. Precipitates
were pelleted, washed once with ice-cold acetone, and dissolved in 30 ml non-reducing SDS-PAGE sample buffer.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analyses comparing equal sample sizes and variances were performed using a two-tailed Student’s t test. All mean values
represent biological replicates. n and p values are found in the figure legends. p values less than 0.05 were considered statistically
significant.
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